Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Acelrx Pharmaceutica (ACRX)

Acelrx Pharmaceutica (ACRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
AcelRx Pharmaceuticals: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

AcelRx Pharmaceuticals: Q3 Earnings Snapshot

ACRX : 0.8600 (+7.50%)
AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study PR Newswire - Tue Oct 3, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

AcelRx Pharmaceuticals: Q2 Earnings Snapshot

ACRX : 0.8600 (+7.50%)
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update PR Newswire - Thu Aug 10, 2023

Capital raise closed in July, led by new healthcare investors; provides access to up to $26.3 million in capital, with $10 million immediately available AcelRx...

ACRX : 0.8600 (+7.50%)
AcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023 PR Newswire - Thu Jul 27, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules PR Newswire - Fri Jul 21, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx" or the "Company"), a specialty pharmaceutical company focused on the development and...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules PR Newswire - Tue Jul 18, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx" or the "Company"), a specialty pharmaceutical company focused on the development and...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals (ACRX) Reports Break-Even Earnings for Q1 Zacks - Wed May 10, 2023

AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises of 100% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ACRX : 0.8600 (+7.50%)
BVS : 4.15 (-3.71%)
AcelRx Pharmaceuticals: Q1 Earnings Snapshot AP - Wed May 10, 2023

AcelRx Pharmaceuticals: Q1 Earnings Snapshot

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire - Wed May 10, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.8600 (+7.50%)

Barchart Exclusives

Is This Pullback Your Best Chance to Buy Nvidia Stock? Barchart - 20 minutes ago
As Nvidia experiences a pullback of approximately 18% from its recent highs, investors might be contemplating whether this presents an opportune moment to scoop up the stock. With concerns about valuation easing and analysts growing more bullish, this analysis explores whether now is the optimal time to consider investing in Nvidia. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot